Global Bioburden Testing Market at A Highest CAGR of 9.09 % to rapidly growing $

Posted by swamiv on November 18th, 2019

Global bioburden testing market By Test Type (Aerobic, Anaerobic, Fungi, Spore), Product Type (Instruments (PCR, Automated Microbial Identification Systems, Microscopes, Others), Consumables (Kits & Strips, Reagents, Others), Technology (Microbial Filter Method, Advanced Colorimetric Method, Plate Count Method, Rapid Testing), Application (Raw Material Testing, In-Process Testing, Medical Device Testing, Pharmaceutical & Cosmetic Testing, Sterilization Validation Testing, Food and Beverage Testing, Equipment Cleaning Validation), End-User (Pharmaceutical, Biotechnology, Industrial, Agriculture,  Food & Beverages, Medical Device Manufacturers, Microbial testing Laboratories)

Market Analysis: Global Bioburden Testing Market

Global bioburden testing market is expected to rise to an estimated value of USD 1121.65 million by 2026 registering a substantial CAGR of 9.9% in the forecast period of 2019-2026. This rise in the market can be attributed to growth in the medical devices, pharma and biotechnology industries, rising concerns of safety and health related to food and beverage products; and rising number of incidences of microbial contamination.

Get inquire before buying @

Market Definition: Global Bioburden Testing Market

Bioburden testing is the method of calculating the load of microorganisms, in or on a medical instrument, raw material, packaged goods among others. The results from bioburden testing are used to determine the sterilization methods to be used while processing the material. Every measurement requires a definitive unit to quantify it; in bioburden testing the unit is CFU (Colony forming Units) per gram or per square centimeter.

Market Drivers

  •          Rising use of bioburden testing for quality check in medical, biotechnological, and pharmaceutical products
  •          Growing awareness amongst people about bioburden testing because of microbial contamination would stimulate the growth of this market
  •          Rising concerns of safety of food and beverages boosts the use of bioburden testing
  •          Rising number of product recalls from the market due to microbial contamination
  •          Rising R&D investment activities in the life sciences and pharma industries
  •          Significant improvements made in the healthcare facilities
  •          Rising number of product recalls and advertisements because of the increased microbial contamination

Market Restraints

  •          Time-consuming and stringent regulatory standards
  •          Expensive cost of instruments

Segmentation: Global Bioburden Testing Market

By Test Type

  •          Aerobic
  •          Anaerobic
  •          Fungi
  •          Spore

By Product Type

  •          Instruments

o    PCR

o    Automated Microbial Identification Systems

o    Microscopes

o    Others

  •          Consumables

o    Kits & Strips

o    Reagents

o    Others

By Technology

  •          Microbial Filter Method
  •          Advanced Colorimetric Method
  •          Plate Count Method
  •          Rapid Testing

By Application

  •          Raw Material Testing
  •          In-Process Testing
  •          Medical Device Testing
  •          Pharmaceutical & Cosmetic Testing
  •          Sterilization Validation Testing
  •          Food and Beverage Testing
  •          Equipment Cleaning Validation

By End User

  •          Pharmaceutical
  •          Biotechnology
  •          Industrial
  •          Agriculture
  •          Food & Beverages
  •          Medical Device Manufacturers
  •          Microbial testing Laboratories

Key Developments in the Market:

In April 2018, Charles River, the beast of bioburden testing, has completely acquired MPI Research, a premier nonclinical contract research organization (CRO). With this purchase Charles River would enrich and expand it client base, by mastering its expertise drug discovery and development continuum.

In October 2018, SGS SA acquired INTER-BASIC RESOURCES, INC. (IBR), a non-clinical contract research organization (CRO). IBR Inc. is a leader in state-of-art testing and biopharma analytics for the construction of biologics, biosimilars and vaccines, and delivers various filter testing and particle counting services. With this acquisition, SGS SA would broaden its filtration services, thereby expand its customer base and customer services.


Competitive Analysis: Global Bioburden Testing Market

Global bioburden testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of bioburden testing market for Global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Bioburden Testing Market

Few of the major market competitors currently working in the bioburden testing market are Charles River, Pacific Bio labs, Inc., Merck KGaA, Darmstadt, Germany and/or its affiliates., SGS S.A., WuXi AppTec, BD., Merck & Co., Inc., North American Science Associates Inc., Nelson Laboratories, LLC, Dynatec Labs, Applied Technical Services, Thermo Fisher Scientific, bioMérieux SA, among others.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.



Data Bridge Market Research

Tel: +1-888-387-2818


Report Related

Global In Vitro Diagnostics (IVD) Quality Control Market

Like it? Share it!


About the Author

Joined: October 30th, 2019
Articles Posted: 149

More by this author